Tau as a biomarker of cognitive impairment and neuropsychiatric symptom in Alzheimer's disease

The A/T/N research framework has been proposed for the diagnosis and prognosis of Alzheimer's disease (AD). However, the spatial distribution of ATN biomarkers and their relationship with cognitive impairment and neuropsychiatric symptoms (NPS) need further clarification in patients with AD. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Dang, Mingxi, Chen, Qian, Zhao, Xiaobin, Chen, Kewei, Li, Xin, Zhang, Junying, Lu, Jie, Ai, Lin, Chen, Yaojing, Zhang, Zhanjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842886/
https://www.ncbi.nlm.nih.gov/pubmed/36647262
http://dx.doi.org/10.1002/hbm.26043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842886/
https://www.ncbi.nlm.nih.gov/pubmed/36647262
http://dx.doi.org/10.1002/hbm.26043

Ejemplares similares